Sol-Gel Technologies Ltd. (SLGL)
64.40
-0.78
(-1.20%)
USD |
NASDAQ |
Sep 15, 16:00
64.42
+0.02
(+0.03%)
After-Hours: 20:00
Sol-Gel Technologies Enterprise Value : 163.69M for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 163.69M |
| September 14, 2026 | 166.24M |
| September 11, 2026 | 168.73M |
| September 10, 2026 | 171.51M |
| September 09, 2026 | 179.34M |
| September 08, 2026 | 179.96M |
| September 04, 2026 | 180.45M |
| September 03, 2026 | 182.35M |
| September 02, 2026 | 183.43M |
| September 01, 2026 | 180.45M |
| August 31, 2026 | 179.07M |
| August 28, 2026 | 178.12M |
| August 27, 2026 | 190.44M |
| August 26, 2026 | 212.89M |
| August 25, 2026 | 220.39M |
| August 24, 2026 | 206.22M |
| August 21, 2026 | 207.33M |
| August 20, 2026 | 209.83M |
| August 19, 2026 | 210.14M |
| August 18, 2026 | 212.57M |
| August 17, 2026 | 224.62M |
| August 14, 2026 | 230.12M |
| August 13, 2026 | 227.99M |
| August 12, 2026 | 186.93M |
| August 11, 2026 | 207.95M |
| Date | Value |
|---|---|
| August 10, 2026 | 230.28M |
| August 07, 2026 | 240.95M |
| August 06, 2026 | 237.35M |
| August 05, 2026 | 240.95M |
| August 04, 2026 | 229.48M |
| August 03, 2026 | 221.28M |
| July 31, 2026 | 222.13M |
| July 30, 2026 | 231.75M |
| July 29, 2026 | 223.09M |
| July 28, 2026 | 224.81M |
| July 27, 2026 | 214.20M |
| July 24, 2026 | 221.18M |
| July 23, 2026 | 216.56M |
| July 22, 2026 | 228.84M |
| July 21, 2026 | 246.65M |
| July 20, 2026 | 215.09M |
| July 17, 2026 | 225.24M |
| July 16, 2026 | 208.47M |
| July 15, 2026 | 205.64M |
| July 14, 2026 | 199.67M |
| July 13, 2026 | 194.82M |
| July 10, 2026 | 194.95M |
| July 09, 2026 | 202.84M |
| July 08, 2026 | 197.61M |
| July 07, 2026 | 209.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 58.95B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 148.10M |
| Purple Biotech Ltd. | -3.246M |
| PolyPid Ltd. | 99.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.681M |
| Revenue (Quarterly) | 0.591M |
| Total Expenses (Quarterly) | 4.272M |
| EPS Diluted (Quarterly) | -1.126 |
| Profit Margin (Quarterly) | -622.8% |
| Earnings Yield | -8.76% |
| Normalized Earnings Yield | -8.765 |